908 organization(s) found
Medicaid Cancer Foundation / Medicaid Radio Diagnostics – Nigeria
Listed among NGO organisations working on cancer advocacy in Nigeria.
Medical & Community Support Organisation Uganda
Civil society organisation working for cancer control and community support in Uganda, listed among cancer-advocacy bodies.
Medicen Paris Region
Health competitiveness cluster of the Paris region.
Medicon Valley Alliance
Life sciences cluster of the Danish-Swedish Øresund region.
Memorial Sloan Kettering Cancer Center
The people of Memorial Sloan Kettering Cancer Center (MSK) are united by a singular mission: ending cancer for life. Our specialized care teams provide personalized, compassionate, expert care to patients of all ages. Informed by basic research done at our Sloan Kettering Institute, scientists across MSK collaborate to conduct innovative translational and clinical research that is driving a revolution in our understanding of cancer as a disease and improving the ability to prevent, diagnose, and treat it. MSK is dedicated to training the next generation of scientists and clinicians, who go on to pursue our mission at MSK and around the globe. One of the world’s most respected comprehensive centers devoted exclusively to cancer, we have been recognized as one of the top two cancer hospitals in the country by U.S. News & World Report for more than 30 years.
MENA Hematology League
The MENA Hematology League was announced on January 21st, 2019, and is licensed as a non-profit organization in the United Kingdom (England and Wales), with registration number 11777391, and is based in London (Unit 3, Office A, 1st Floor, 6-7 St Mary at Hill, London, England EC3R 8EE). [ https://find-and-update.company-information.service.gov.uk/company/11777857 ]. The League was founded by Prof. Ahmad Tarawah. To date, 21 Middle East countries have been represented in the league. The MENA Hematology League is managed by a board of directors representing MENA countries. The league has eight offices distributed in the United Kingdom, Saudi Arabia, Egypt and the United Arab Emirates. More than 35,000 members are registered. Three congresses and more than ten forums have been conducted in Saudi Arabia, Egypt, Algeria, Yemen and Qatar. More than 500 research studies have been presented at MENA congresses and published in medical journals.
Menarini
High quality therapeutics and diagnostics solutions for patients, ethics as our underlying principle, dedication to innovation and advancement, strong people centricity and environmental sustainability. These five pillars form the foundation of the Menarini Group, an Italian pharmaceutical company with more than 135 years of history.
Merck
As a vibrant science and technology company, there's nothing small in what we do.
Mestag Therapeutics
Mestag is an immunology company driving first-in-class treatments for cancer and inflammatory diseases. Through our unique understanding of fibroblast biology, we are rapidly advancing a pipeline of sophisticated agonist antibody programs and exploring our RAFT target discovery platform to identify new targets for the development of new treatments.
Micro CRISPR
Accelerating the synthetic biology revolution, one gene at a time: Micro CRISPR is a new age biotechnology company with an outlier mindset on a quest to improve millions of lives. We strive to lead with our core values and to help spread ideas of sustainability and responsibility whose impact can reach far beyond our own business.
Miltenyi Biotec
Company that supplies cell separation, flow cytometry and cell therapy manufacturing technologies.
MIN (Melbourne Immunotherapy Network)
The Melbourne Immunotherapy Network (MIN) was launched in 2016 by University of Melbourne Professors Dale Godfrey, Sharon Lewin and Fabienne Mackay at the Doherty Institute, and Professors Joe Trapani and Professor Ricky Johnstone, from The Peter MacCallum Cancer Centre. This network was set-up to harness and combine the immunology and immuno-oncology excellence in the Melbourne area by bringing together researchers across Melbourne to present what’s new in the Immunotherapy related field.
MMRF (Multiple Myeloma Research Foundation)
US foundation that funds and runs research programmes on multiple myeloma.
Moderna
Our mission is to deliver the greatest possible impact to people through mRNA medicines.
Modern Cancer Hospital (Guangzhou)
A private / possibly international-serving cancer hospital — represents non-state/private sector involvement in cancer care and potentially alternative treatment routes (esp. for foreign or affluent patients). (Less publicly documented)
MOGA (Medical Oncology Group of Australia)
The professional organisation for Australian Medical Oncologists; a specialty society of the Royal Australasian College of Physicians, and represents Medical Oncology specialists at the national level. MOGA contributes to the training of Medical Oncologists in Australia and advocates for improved access, affordability, and management of cancer both nationally and globally.
Monash University
Monash is a modern, global, research-intensive university, delivering education and research excellence in Australia and across the Indo-Pacific. We’re making a positive impact on today's global challenges – whether that’s by mitigating climate change, easing geopolitical insecurity or fostering healthy communities.
Monte Rosa Therapeutics
Our pipeline of Molecular-Glue Degraders (MGDs) represents a new approach to selectively edit the human proteome and eliminate therapeutically relevant proteins.